31P MRS analysis of the phospholipid composition of the peripheral blood mononuclear cells (PBMC) and bone marrow mononuclear cells (BMMC) of patients with acute leukemia (AL)

Cellular and Molecular Biology Letters

Volumn 14, Issue 1, 2009, Pages 35-45

  Kuliszkiewicz Janus, Małgorzata ^a,b   Tuz, Mariusz Adam ^a   Kiełbiński, Marek ^a   Jaźwiec, Bozena ^a   Niedoba, Joanna ^a   Baczyński, Stanisław ^c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Academic Centre for the Biotechnology of Lipid Aggregates   (Poland)

^c UNIVERSITY OF WROC AW   (Poland)

Author keywords

31P MRS; Acute leukemia; Phospholipids

Indexed keywords

CARDIOLIPIN; MEDRONIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLASMINOGEN; SPHINGOMYELIN; BISPHOSPHONIC ACID DERIVATIVE; CELL EXTRACT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; BLOOD; BONE MARROW CELL; CHEMISTRY; MIDDLE AGED; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; BONE MARROW CELLS; CELL EXTRACTS; DIPHOSPHONATES; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOLIPIDS;

EID: 58949095538     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-008-0032-7     Document Type: Article

References (29)

1. 31P MRS spectra of sera from patients with multiple myleoma. NMR Biomed. 8 (1995) 127-132.
2. 31P NMR spectroscopy to monitor chemotherapy-associated changes of serum phospholipids in patients with malignant lymphomas. Magn. Reson. Med. 35 (1996) 449-456.
3. 31P MRS (magnetic resonance spectroscopy) spectra of sera from patients with acute leukemia. Biochim. Biophys. Acta 1360 (1997) 71-83.
4. 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers. Anticancer Res. 16 (1996) 1587-1594.
5. Kuliszkiewicz-Janus, M., Janus, W., Baczyñski, S. and Jurczyk, A. Bone marrow transplantation In the course of hematological malignancies- fellow up to study in blond serum by 31P NMR. Med. Sci. Monit. 10 (2004) 485-492. (Pubitemid 39166438)
6. 31P NMR to the analysis of phospholipids changes in plasma of patients with acute leukemia. Biochim. Biophys. Acta 1737 (2005) 11-15.
7. 31P MRS in vitro. NATO Science Series. II: Mathematics, Physics and Chemistry 76 (2002) 347-354.
8. 31P NMR magnetic resonance spectroscopy to observation of phospholipids concentration changes in blood serum, plasma, peripheral blood mononuclear cells and bone marrow mononuclear cell from patients with hematological cancers - a methodological review. Polish J. Chem. 80 (2006) 1009-1019.
9. Kuliszkiewicz-Janus, M., Tuz, M.A., Kiełbiński, M., Baczyński, S., Jaźwiec, B. and Śladowska, H. Platelet-activating factor changes In phospholipid extracts from plasma, peripheral blood mononuclear cells and bone marrow mononuclear cell of patients with acute leukemia - A 31P NMR in vitro study. Cell. Mol. Biol. Lett. 13 (2008) 58-66. (Pubitemid 351679944)
10. Kuliszkiewicz-Janus, M., Tuz, M.A., Baczyński, S., Prajs, I. and Jaźwiec, B. 31P NMR analysis of the phospholipid composition of mormal human peripheral blond mononuclear cells (PBMC). Cell. Mol. Biol. Lett. 10 (2005) 373-382. (Pubitemid 41564511)
11. 31P NMR. NMR Biomed. 6 (1993) 187-193.
12. 31P NMR study. NMR Biomed. 12 (1999) 184-188.
13. van Blitterswijk, W.J., van der Luit, A.H., Veldman, R.J., Verheij, M. and Borst, J. Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem. J. 369 (2003) 199-211. (Pubitemid 36174190)
14. Tepper, A.D., Ruurs, P., Wiedmer, T., Sims, P.J., Borst, J. and van Blitterswijk, W.J. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipids scrambling and alters cell-surface morphology. J. Cell Biol. 150 (2000) 155-164. (Pubitemid 30480234)
15. Bevers, EM., Comfurius, P., Dekkers, D.W. and Zwaal, R.F. Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta 1439 (1999) 317-330. (Pubitemid 29371798)
16. Verhoven, B., Schlegel, R.A. and Williamson, P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lyphocytes. J. Exp. Med. 182 (1995) 1597-1601.
17. Martin, S.J., Reutelingsperger, C.P., McGahon, A.J., Rader, J.A., van Schie, R.C., LaFace, D.M. and Green, D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182 (1995) 1545-1556.
18. Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L. and Henson, P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 (1992) 2207-2216.
19. Kagan, V.E., Fabisiak, J.P., Shvedova, A.A., Tyurina, Y.Y., Tyurin, V.A., Schor, N.F. and Kawai, K. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett. 477 (2000) 1-7. (Pubitemid 30438848)
20. McConkey, D.J., Zhitovsky, B. and Orrenius, S. Apoptosis - molecular mechanisms and biomedical implications. Mol. Aspects Med. 17 (1996) 1-110. (Pubitemid 26169416)
21. Eberhardt, C., Gray, P.W. and Tjoelker, L.W. Human lysophosphatidic acid acytylotransferase. CDNA clonning, expression, and localization to chromosome 9q34.3. J. Biol. Chem. 272 (1997) 20299-20305. (Pubitemid 27340144)
22. Niesporek, S., Denkert, C., Weichert, W., Kobel, M., Noske, A., Sehouli, J., Singer, J.W., Dietel, M. and Hauptmann, S. Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis. Br. J. Cancer 92 (2005) 1729-1736. (Pubitemid 40756485)
23. Springett, G.M., Bonham, L., Hummer, A., Linkov, I., Misra, D., Ma, C., Pezzoni, G., Di Giovine, S., Singer, J., Kawasaki, H., Spriggs, D., Soslow, R. and Dupont, J. Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies. Cancer Res. 65 (2005) 9415-9425. (Pubitemid 41508010)
24. Douvas, M.G., Hogan, K.N., Ji, Y., Hollenback, D., Bonham, L., Singer, J.W. and Mitchell, B.S. Effect of lysophosphatidic acid acyltransferase-beta inhibition in acute leukemia. Leuk. Res. 30 (2006) 1027-1036. (Pubitemid 43831183)
25. Ruiz-Cabello, J. and Cohen, J.S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 5 (1992) 226-233.
26. Gerhard, A., Häfer, R. and Zintl, F. Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukaemia. Cancer Lett. 173 (2001) 139-144. (Pubitemid 32971931)
27. Lin, W.C., Manshouri, T., Jilani, I., Neuberg, D., Patel, K., Kantarjian, H., Andreeff, M., Estrov, Z., Beran, M., Keating, M., Estey, E. and Albitar, M. Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. Leuk. Res. 26 (2002) 551-559. (Pubitemid 34462169)
28. Shuler, D. and Szende, B. Apoptosis in acute leukaemia. Leuk. Res. 28 (2004) 661-666.
29. Invernizzi, R., Pecci, A., Bellotti, L. and Ascari, E. Expression of p53, Bcl-2 and Ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes. Leuk. Lymphoma 42 (2001) 481-489. (Pubitemid 32725604)